The KPV tripeptide is a small-molecule peptide composed of lysine (Lys), proline (Pro), and valine (Val). As the C-terminal fragment of alpha-melanocyte-stimulating hormone (α-MSH), it retains potent anti-inflammatory activity without the side effect of melanogenesis (pigmentation). It holds significant research value in the field of biomedicine. Below is a detailed overview, including its primary applications and mechanisms of action.

Basic Overview

Chemical Properties: Its chemical formula is C₁₆H₃₀N₄O₄, with a molecular weight of 342.44 g/mol and a CAS registry number of 67727-97-3. It exhibits excellent water solubility and biocompatibility, is non-immunogenic, can be naturally degraded by enzymes within the body, and possesses a high safety profile. The substance requires storage at temperatures between -80°C and -20°C and is typically produced via chemical synthesis.

Core Characteristics: Unlike its parent molecule, α-MSH, the KPV tripeptide does not induce melanogenesis. This property prevents side effects such as abnormal skin pigmentation during treatment, making it an excellent candidate for research into inflammation-related diseases.

Primary Applications

Treatment of Inflammatory Bowel Disease (IBD): This is a key area of ​​research for the KPV tripeptide. In studies, it is often encapsulated within carriers—such as hyaluronic acid-functionalized nanoparticles or chitosan/alginate hydrogels—to achieve targeted delivery. This approach helps reduce inflammation in the colon and accelerates mucosal healing. In mouse models of ulcerative colitis, KPV-containing formulations have been shown to effectively reduce mucosal damage, demonstrating significant therapeutic potential for this type of inflammatory bowel disease.

Adjunctive Treatment for Skin-Related Conditions: On one hand, it is used in research concerning inflammatory skin conditions such as eczema, psoriasis, and dermatitis; it alleviates skin inflammation and reduces lesions by exerting anti-inflammatory effects and modulating immune responses. On the other hand, it facilitates wound healing. In animal models involving pressure ulcers or diabetic wounds, for instance, it has been shown to regulate immune responses, accelerate tissue repair, and promote the regeneration of skin epithelial cells. Furthermore, KPV-modified liposomes can be used in the synergistic treatment of vitiligo; they not only protect melanocytes but also facilitate melanin synthesis.

Adjunctive treatment for infections: Possessing certain antibacterial properties, these liposomes can serve as an adjunct in the treatment of infections affecting the skin and mucous membranes.

.

•⁠  ⁠Credit/Debit Card  

•⁠  ⁠Apple Pay  

•⁠  ⁠Google Pay  

•⁠  ⁠Alibaba Pay (secure link)  

•⁠  ⁠Bank Transfer (SWIFT)   

•⁠  ⁠USDT (TRC20)  

•⁠  ⁠Bitcoin (BTC)

•⁠  ⁠Paypal